Page last updated: 2024-11-08

1-deoxy-1-morpholinofructose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6454484
SCHEMBL ID8098959
MeSH IDM0130883

Synonyms (9)

Synonym
1-dmf
(3s,4r,5r)-1,3,4,5,6-pentahydroxy-1-morpholin-4-ylhexan-2-one
1-deoxy-1-morpholinofructose
ai3-18907
d-fructose, 1-deoxy-1-(4-morpholinyl)-
SCHEMBL8098959
morpholino-fructose
1-c-morpholin-4-ylhex-2-ulose
DTXSID50978700

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The selection of serum albumin and the concentration used in the standard solutions is critical since the dose-response curve is affected differently and will therefore influence the estimated values."( The estimation of serum fructosamine: an alternative measurement to glycated haemoglobin.
Gatt, JA; Hindle, EJ; Rostron, GM, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (47.37)18.7374
1990's1 (5.26)18.2507
2000's7 (36.84)29.6817
2010's2 (10.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]